BioNTech is headquartered in Mainz, Germany.
BioNTech disclosed revenue of 2,751M EUR for 2024 and 3,819M EUR for 2023.
BioNTech has 6,133 employees.
BioNTech is a life science company.
BioNTech was founded in 2008.
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators. BioNTech founded in 2008 and is based in Mainz, Germany.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.8/yr) | # | 2 | 1 | - | 1 | 1 | 1 | 6 |
| vol | $67M | $557M | $800M | $1.3B | $2.7B | |||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 6 | ||||||||
| Financial | Deals |
|---|---|
|
PJT Partners |
1 |
| Legal | Deals |
|---|---|
|
Covington & Burling |
2 |
|
Hengeler Mueller |
1 |
|
Loyens & Loeff |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
